Janus kinase 3: the controller and the controlled
Authors:
Open Access
- 29 November 2011
- journal article
- review article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 44 (3) , 187-196
Abstract
Janus kinase (JAK)-signal transducer and activators of transcription (STAT) signaling pathways play crucial roles in lymphopoiesis. In particular, JAK3 has unique functions in the lymphoid system such that JAK3 ablation results in phenotypes resembling severe combined immunodeficiency syndrome. This review focuses on the biochemistry, immunological functions, and clinical significance of JAK3. Compared with other members of the JAK family, the biochemical properties of JAK3 are relatively less well characterized and thus largely inferred from studies of JAK2. Furthermore, new findings concerning the cross-talks between Notch and JAK signaling pathways through ubiquitin-mediated protein degradation are discussed in more detail.Keywords
This publication has 98 references indexed in Scilit:
- A Mechanism Underlying NOTCH-Induced and Ubiquitin-mediated JAK3 DegradationJournal of Biological Chemistry, 2011
- An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiationInternational Immunology, 2011
- A novel tumour-suppressor function for the Notch pathway in myeloid leukaemiaNature, 2011
- Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexesCell Research, 2010
- JAK3: A two-faced player in hematological disordersThe International Journal of Biochemistry & Cell Biology, 2009
- The SOCS Box Domain of SOCS3: Structure and Interaction with the ElonginBC-Cullin5 Ubiquitin LigaseJournal of Molecular Biology, 2008
- Therapeutic targeting of Janus kinasesImmunological Reviews, 2008
- Janus-Kinase-3-Dependent Signals Induce Chromatin Remodeling at the Ifng Locus during T Helper 1 Cell DifferentiationImmunity, 2008
- Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2The EMBO Journal, 2006
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005